
The Mesothelioma Center News – Page 5
-
Research & Clinical TrialsStandard-of-care treatment for malignant mesothelioma could change significantly, depending upon the results of an upcoming clinical trial of two immunotherapy agents used in…
-
Treatment & Doctors
More Mesothelioma Cancer Centers Using Tumor Treating Fields
Tumor Treating Fields is one of the newest treatments on the market for pleural mesothelioma cancer patients with metastatic disease. The device is…July 21, 2020 -
Asbestos Exposure & Bans
EPA Leaving Libby After Massive Asbestos Cleanup
Mike Cirian came to Libby, Montana, in 2005 to lead the largest asbestos cleanup project in American history, a decontamination effort of…July 15, 2020 -
Asbestos Exposure & Bans
Nonprofits Call for Worldwide Halt of J&J Baby Powder Sales
National advocacy group Black Women for Wellness joined more than 170 other nonprofits from 51 countries last week in demanding that Johnson &…July 13, 2020 -
Research & Clinical Trials
NCI Studying New Mesothelioma Immunotherapy Combination
Patients with mesothelioma are being recruited by the National Cancer Institute for a phase II clinical trial using a novel immunotoxin prior…July 8, 2020 -
Legislation & Litigation
Rise in Talc Cases Reshapes Traditional Asbestos Litigation
A recent rise in litigation linking cosmetic talc with mesothelioma and lung cancer will continue throughout 2020, despite companies abandoning the product in…July 7, 2020 -
Research & Clinical Trials
Cryoablation Study for Mesothelioma Opening at UCLA
Researchers at UCLA Jonsson Comprehensive Cancer Center will soon begin studying the pre-surgery use of cryoablation as a potential early adjuvant therapy for…July 1, 2020 -
Asbestos Exposure & Bans
Johnson & Johnson Talc-Asbestos Verdict Upheld, Award Cut
The Missouri Court of Appeals upheld a landmark jury verdict that said long-term use of Johnson & Johnson’s talc products, possibly contaminated with…June 25, 2020 -
Research & Clinical Trials
Tazemetostat Shows Promise for Pleural Mesothelioma
Five different research groups at the American Society of Clinical Oncology annual meeting last month made presentations on the effectiveness of tazemetostat, a novel…June 24, 2020 -
Research & Clinical Trials
Mesothelioma Chemoperfusion Trial Shows Impressive Results
Study statistics show the benefits of the novel transarterial chemoperfusion treatment being used successfully at the Moffitt Cancer Center in Tampa for patients with…June 22, 2020